PharmacOdynamic compaRison of piTavastatin Versus atOrvastatin on Platelet Reactivity
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 100 participants.
Also called NCT01648829
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose diagnostic
- Phase
- Phase 4
- Enrolled
- 100 participants
- Registry
-
NCT01648829
-
- Start date
- (registry gives no type)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Italy
- Registry status
- Unknown status
Technical summary
Registry record NCT01648829. Randomized; quadruple masking; primary purpose diagnostic. Start 2014-01 (registry gives no type); primary completion 2015-12 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- PharmacOdynamic compaRison of piTavastatin Versus atOrvastatin on Platelet Reactivity
- Acronym
- PORTO
- Condition
- Coronary Artery Disease
- Intervention (Drug)
- Atorvastatin
- Intervention (Drug)
- Pitavastatin
- Lead sponsor
- University of Roma La Sapienza
Record details
- Record id
cardio:ct-nct01648829- Content hash
dbf5d71779760cb2476365505c019834d333fa9136cb92118565ec701c630e6f